This effect might also be related to the ability of ACF to block HIF-1 signaling in oligodendrocyte precursor cells, which further benefits remyelination or at least might prevent Olig2+cells from dying in the EAE model of MS. Here, OLIG2 is linked to myeloid sarcoma.